Sucralfate Tablet
FDA Label NDC 55154-4379

26 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Sucralfate (NDC 55154-4379). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, therapeutic category, clinical pharmacology, acute duodenal ulcer, maintenance therapy after healing of duodenal ulcer, indications and usage, contraindications, precautions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-4379-0

SUCRALFATE TABLETS, USP

1 gram

10 TABLETS

1gram Bag Label (3a87770c Fa4f D061 E063 6294a90a6751 00)

1gram Bag Label (3a87770c Fa4f D061 E063 6294a90a6751 00)

* Please review the disclaimer below.